CBT/CM: Cognitive-Behavioral Treatment of Gambling

Sponsor
UConn Health (Other)
Overall Status
Completed
CT.gov ID
NCT00118391
Collaborator
National Institute of Mental Health (NIMH) (NIH)
120
1
35
3.4

Study Details

Study Description

Brief Summary

This study will determine the effectiveness of cognitive behavior therapy (CBT) and contingency management (CM) in reducing gambling behaviors and other related problems in pathological gambling.

Study hypothesis: Participants who receive CBT and CM will attend more treatment sessions and show better outcomes than those who receive CBT alone.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive behavior therapy
  • Behavioral: Contingency management
Phase 1

Detailed Description

Pathological gambling has become an increasingly problematic condition in the United States, often causing serious financial, psychological, and public health consequences. In an effort to treat this growing problem, researchers have evaluated numerous therapies; one such therapy is CBT. CBT has been shown to improve pathological gambling outcomes. However, evidence suggests that adding CM to CBT could result in even more improved outcomes. This study will compare the effectiveness of CBT and CM with that of CBT alone in reducing pathological gambling.

This study will last 12 months. Participants will be randomly assigned to receive either CBT and CM or CBT alone for 8 weeks. CBT will focus on reducing gambling urges and helping patients develop alternative behaviors to gambling. CM will focus on encouraging patients to avoid gambling. Participants in the CBT and CM group will receive voucher incentives for completing homework assignments and engaging in non-gambling social activities. The vouchers will allow participants to take part in non-gambling activities of their choice. Changes in gambling activities and problems will be assessed with self-report scales and interviews at study start and at Weeks 10, 24, and 52.

Participants will be asked to identify at least one person who knows about their gambling and will have regular contact with them over the 12 months of the study. This person will be interviewed at study start and at Months 2, 6, and 12. Contact persons will be asked about participants' gambling behaviors, personal relationships, legal problems, use of health care and mental health services, and how the participant can be contacted if he or she moves.

For information on related studies, please follow these links:

http://clinicaltrials.gov/show/NCT00158314

http://clinicaltrials.gov/show/NCT00618462

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Enhanced Cognitive Behavior Therapy for the Treatment of Pathological Gambling
Study Start Date :
Nov 1, 2002
Actual Primary Completion Date :
Oct 1, 2005
Actual Study Completion Date :
Oct 1, 2005

Outcome Measures

Primary Outcome Measures

  1. Addiction Severity Index (ASI) gambling severity scores []

  2. amount spent gambling per gambling episode []

  3. longest period of non-gambling []

  4. days until first gambling episode []

  5. percent of days gambling []

  6. proportion meeting diagnostic criteria []

  7. number of treatment sessions attended []

Secondary Outcome Measures

  1. Psychosocial functioning []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of pathological gambling

  • At least 1 gambling episode within 30 days prior to study entry

  • Able to read English at a 5th grade level

  • Willing and able to comply with all study requirements

Exclusion Criteria:
  • Uncontrolled psychiatric conditions

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Connecticut Health Center Farmington Connecticut United States 06030

Sponsors and Collaborators

  • UConn Health
  • National Institute of Mental Health (NIMH)

Investigators

  • Principal Investigator: Nancy M. Petry, PhD, UConn Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00118391
Other Study ID Numbers:
  • R01MH060417-02
  • R01MH060417-02
First Posted:
Jul 11, 2005
Last Update Posted:
Jul 1, 2013
Last Verified:
Jun 1, 2013
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 1, 2013